In our first live webinar about extracorporeal shock wave lithotripsy (SWL) Prof. Dr Palle Osther talks about »SWL in the Era of Endourology«.
In our third live webinar about extracorporeal shock wave lithotripsy (SWL) Dr Ranan DasGupta and Dr Milad Hanna talk about »Achieving Excellence in SWL: How Far Can We Go?«.
After attending two virtual congresses, innovative companies, physicians and specialists in urology once again met in person for the 37th Annual Congress of the European Association of Urology (EAU) in Amsterdam (1–4 July 2022). Together with KARL STORZ, STORZ MEDICAL presented...
The established and US-market leading MODULITH SLX-F2 extracorporeal shock wave lithotripter from STORZ MEDICAL has recently received the FDA 510 (k) clearance for new indications. With this clearance, an absolutely unique selling point for STORZ MEDICAL is that children over the age of three years suffering of stone disease can now be treated non-invasively(*1,2, 3). The MODULITH SLX-F2 is the first and the only lithotripter available for lithotripsy in children in the USA.
In 2021, COVID-19 continues to cause a global emergency that is dominating our professional and personal lives. Nevertheless, other ailments such as stone disease have not simply disappeared as a result of the coronavirus pandemic.
The clinical film shows the process of an extracorporeal shock wave lithotripsy (SWL) with the MODULITH® SLX-F2 »connect« and shares the perspectives of both doctor and patient.